புற்றுநோய்கள் மெய்நிகர் ஆண்டு சிம்போசியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Zai Lab Announces Financial Results for Second-half and Full-year 2020
March 01, 2021 07:00 ET
| Source:
Zai Lab Limited
Zai Lab Limited
Company to Host Conference Call and Webcast Today at 8:00 a.m. ET
SHANGHAI and SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today reported financial results for the second half and full year of 2020, along with corporate updates.
“2020 was another year of great accomplishment for Zai Lab,” said Dr. Samantha Du, Founder, Chairperson and Chief Executive Officer of Zai Lab. “We successfully launched ZEJULA for both second-line and first-line ovarian cancer and Optune for glioblastoma in China. We submitted NDAs and were granted priority reviews by China’s National Medical Products Administration (NMPA) for both QINLOCK for advanced gastrointestinal stromal tumors (GIST) and NUZY ....

United States , United Kingdom , Hong Kong , Dburns Mcclellan , Mike Zanoni , Alan Sandler , Optune Lua , Billy Cho , Ryo Imai Robert Flamm , Zai Lab , Zai Lab Limited , China National Medical Products Administration , European Union , Zai Lab Forward , Society For Immunotherapy Of Cancer , Drug Administration , Zai Lab Annual Report On Form , Company To Host Conference Call , China National Healthcare Security Administration , Exchange Commission , Hong Kong Department Of Health , National Reimbursement Drug List , Head Of Global Development , Business Development , Host Conference Call , Webcast Today ,